English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [5139]
News [14895]
Articles [105]
Editorials [3]
Conferences [246]
elearning [21]
Cost of cancer treatment can impact health of survivors
Cost of cancer treatment can impact health of survivors
AI helps detect pancreatic cancer
AI helps detect pancreatic cancer
ESMO 2022: Sotorasib demonstrates superior PFS versus docetaxel for previously treated NSCLC with KRAS G12C mutation
ESMO 2022: Sotorasib demonstrates superior PFS versus docetaxel for previously treated NSCLC with KRAS G12C...
ESMO 2022: ADAURA trial results provide new hope for patients with early-stage non-small cell lung cancer
ESMO 2022: ADAURA trial results provide new hope for patients with early-stage non-small cell lung cancer
ESMO 2022: A new era of early cancer detection with blood test may change cancer screening paradigms
ESMO 2022: A new era of early cancer detection with blood test may change cancer screening paradigms
ESMO 2022: Nivolumab ipilimumab combo does not improve DFS for RCC after nephrectomy
ESMO 2022: Nivolumab ipilimumab combo does not improve DFS for RCC after nephrectomy
ESMO 2022: Pembrolizumab with CRT vs placebo plus CRT for locally advanced HNSCC
ESMO 2022: Pembrolizumab with CRT vs placebo plus CRT for locally advanced HNSCC
ESMO 2022: Strong potential for neoadjuvant nivolumab plus ipilimumab to become standard of care for locally advanced MMR-deficient colon cancer
ESMO 2022: Strong potential for neoadjuvant nivolumab plus ipilimumab to become standard of care for locally...
ESMO 2022: Scientists discover how air pollution may trigger lung cancer in never-smokers
ESMO 2022: Scientists discover how air pollution may trigger lung cancer in never-smokers
ESMO 2022: Impressive results for the patients with rare cancers in the DeFi Trial
ESMO 2022: Impressive results for the patients with rare cancers in the DeFi Trial
<1...275276277278279...1490>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top